SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q/A - Quarterly report [Sections 13 or 15(d)]: [Amend]
SEC Accession No. 0001683168-24-001682
Filing Date
2024-03-25
Accepted
2024-03-25 17:25:12
Documents
59
Period of Report
2023-09-30

Document Format Files

Seq Description Document Type Size
1 AMENDMENT NO. 1 coeptis_i10qa-093023.htm   iXBRL 10-Q/A 1510859
2 CERTIFICATION coeptis_ex3101.htm EX-31.1 7548
3 CERTIFICATION coeptis_ex3102.htm EX-31.2 7540
4 CERTIFICATION coeptis_ex3201.htm EX-32.1 2468
5 CERTIFICATION coeptis_ex3202.htm EX-32.2 2465
  Complete submission text file 0001683168-24-001682.txt   8234257

Data Files

Seq Description Document Type Size
6 XBRL SCHEMA FILE coep-20230930.xsd EX-101.SCH 48909
7 XBRL CALCULATION FILE coep-20230930_cal.xml EX-101.CAL 50215
8 XBRL DEFINITION FILE coep-20230930_def.xml EX-101.DEF 218001
9 XBRL LABEL FILE coep-20230930_lab.xml EX-101.LAB 318002
10 XBRL PRESENTATION FILE coep-20230930_pre.xml EX-101.PRE 277672
62 EXTRACTED XBRL INSTANCE DOCUMENT coeptis_i10qa-093023_htm.xml XML 1836688
Mailing Address 105 BRADFORD ROAD, SUITE 420 WEXFORD PA 15090
Business Address 105 BRADFORD ROAD, SUITE 420 WEXFORD PA 15090 724-934-6467
Coeptis Therapeutics Holdings, Inc. (Filer) CIK: 0001759186 (see all company filings)

IRS No.: 981465952 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q/A | Act: 34 | File No.: 001-39669 | Film No.: 24780227
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)